Brief: Murphy Canyon Acquisition Corp- Enters Into A Definitive Business Combination Agreement With Conduit Pharmaceuticals Limited

CDT Equity

08/11/2022 23:19

Nov 8 (Reuters) - Murphy Canyon Acquisition Corp
 MURF.O :
    * MURPHY CANYON ACQUISITION CORP-  ENTERED INTO A DEFINITIVE
BUSINESS COMBINATION AGREEMENT WITH CONDUIT PHARMACEUTICALS
LIMITED
    * MURPHY CANYON ACQUISITION CORP-  ENTERED INTO A DEFINITIVE
BUSINESS COMBINATION AGREEMENT WITH CONDUIT MERGER SUB, INC
    * MURPHY CANYON ACQUISITION CORP- PURSUANT TO AGREEMENT
CONDUIT
MERGER SUB TO MERGE WITH AND INTO CONDUIT, WITH CONDUIT
SURVIVING AS UNIT OF COMPANY
    * MURPHY CANYON ACQUISITION CORP- COMPANY IS EXPECTED TO BE
RENAMED CONDUIT PHARMACEUTICALS INC. AT THE CLOSING OF THE
BUSINESS COMBINATION
    * MURPHY CANYON ACQUISITION CORP- SHALL DELIVER TO
SHAREHOLDERS 
SHARES OF CO’S COMMON STOCK WITH VALUE OF$650 MILLION, EACH
SHARE VALUED AT $10.00 PER SHARE

Source text for Eikon:  ID: 
Further company coverage:  MURF.O 
 ((Reuters.Briefs@thomsonreuters.com;))